IRCT20210825052293N1
Recruiting
Phase 3
Evaluation of the effect of selenium supplemention on cancer-related fatigue in outpatient cancer patients and comparison of it with placebo effect in control group
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Cancer-related fatigue.
- Sponsor
- Esfahan University of Medical Sciences
- Enrollment
- 70
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •30 to 60 years of age
- •To be able to read and write
- •Definitive diagnosis of cancer which requires chemotherapy and has been confirmed with pathology findings and authenticated by an oncology subspecialist
- •Not having another treatment regimen that has healing effect on fatigue
- •To have cancer\-related fatigue and score of 40 and above in fatigue questionnaire
- •To tolerate oral medication
- •To cooperate and agree with the study
Exclusion Criteria
- •Patients with known depression undergoing treatment
- •Having anemia
- •Having a disease that prevents patient from continuing participation in study
- •When more than 20% of the questionnaire has not been completed
- •Pregnancy and lactation
- •Renal failure
- •Taking medications such as baloxavir, marboxil, deferiprone, cabotegravir, bisphosphonate derivatives, bictegravir, dolutegravir, eltrombopag, trientine, raltegravir, penicillamine, elvitegravir
- •Known allergy to selenium
- •Hypothyroidism
- •Skin cancer and individulas at high risk for developing squamous cell carcinoma
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Evaluation of the effect of selenium on patients with thyroid cancer treated with radioactive iodineThyroid cancer.Neoplasm of uncertain behavior of thyroid glandD44.0IRCT20201129049534N6Esfahan University of Medical Sciences60
Completed
Phase 3
Determining the effect of Selenium supplementation on CD4+ T lymphocyte count in HIV+ patients refered to Iranian HIV/AIDS Research Center (IRCHA)HIV infection.Unspecified human immunodeficiency virus [HIV] diseaseIRCT138904244380N2Vice Chancellor For Research, Tehran University of Medical Sciences100
Recruiting
Phase 3
effect of selenium in systemic lupus erythematosusIRCT20210717051914N2Ahvaz University of Medical Sciences56
Completed
Phase 3
Effects of selenium supplementation on glucose homeostasis in women with GDMGestational diabetes mellitus.Diabetes mellitus in pregnancyIRCT2017041933297N1Vice chancellor for research, Shiraz University Of medical Science50
Completed
Phase 3
Effect of selenium on malnutrition- inflamation complex syndrome (MICS) in hemodialysis patientsEnd stage renal disease , hemodialysis.Chronic renal failureIRCT138812043408N1Shiraz University of Medical Sciences80